Every recall we track for Akcea Therapeutics, Inc. — 1 in all, all from 2022 — plus the complaints and injury reports the public filed about them.
1 recall from Akcea Therapeutics, Inc. are on record with U.S. safety agencies, from 2022.
Akcea Therapeutics, Inc. recalls Tegsedi (inotersen) Injection 284 mg/1.5 mL, Rx Only, Sterile solution for Subcutaneous Use, 4 prefilled syringes, each, dated May 23, 2022. Every Akcea Therapeutics, Inc. recall is listed on this page, newest first.
Match the NDC and lot number on your bottle or box to the recall. Don’t stop a prescription on your own — ask your pharmacist or doctor for a replacement first. Report side effects to FDA MedWatch.
Sign up for free email alerts on GovInfoNow — we check official CPSC, FDA, USDA and NHTSA data every day and email you only when a recall matches what you follow.
